Skip to main content

Female Surgeons Have Lower Rates of Adverse Postoperative Outcomes

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Sept. 1, 2023 -- Patients treated by female surgeons have a lower likelihood of adverse postoperative outcomes, including death, at 90 days and one year postsurgery, according to a study published online Aug. 30 in JAMA Surgery.

Christopher J.D. Wallis, M.D., Ph.D., from Mount Sinai Hospital in Toronto, and colleagues examined whether surgeon sex is associated with 90-day and one-year outcomes among patients undergoing common surgeries. The analysis included more than 1.16 million Canadian adults undergoing one of 25 common elective or emergent surgeries from 2007 through 2019.

The researchers found that overall, 14.3 percent of patients had one or more adverse postoperative outcomes at 90 days and 25.0 percent had one or more adverse postoperative outcomes one year postsurgery. For the composite of death, readmission, or complication, rates were higher among patients treated by male than female surgeons at both 90 days (13.9 versus 12.5 percent; adjusted odds ratio [aOR], 1.08; 95 percent confidence interval [CI], 1.03 to 1.13) and one year (25.0 versus 20.7 percent; aOR, 1.06; 95 percent CI, 1.01 to 1.12), when adjusting for patient, procedure, surgeon, anesthesiologist, and hospital characteristics. Findings were similar for mortality at 90 days (0.8 versus 0.5 percent; aOR, 1.25; 95 percent CI, 1.12 to 1.39) and one year (2.4 versus 1.6 percent; aOR, 1.24; 95 percent CI, 1.13 to 1.36).

"These findings further support differences in patient outcomes based on physician sex that warrant deeper study regarding underlying causes and potential solutions," write the authors.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...

Odds of Death Lower With Surgery for Hip Fracture in Patients With Dementia

MONDAY, June 3, 2024 -- For community-dwelling patients with dementia and fracture of the femoral head and neck, the odds of death are lower for those treated surgically...

Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income

FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.